Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

CoreAge Rx vs Tryozi

Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

Published by The GLP-1 Verdict

Pricing sources checked: CoreAge Rx: August 2026 · Tryozi: Check date not recorded

WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx
vs
Grade C · #71

Tryozi

A Florida telehealth that names all four of its compounding pharmacies and now sells brand-name Ozempic and Zepbound alongside compounded injections, but leads with a half-price first month.

Visit Tryozi

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 76/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Tryozi still earns its place — buyers who want the compounding pharmacy named outright and a price that does not climb as the dose escalates.

The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

92Real-world results70
97Price honesty84
96Prescriber access78
88Formulary choice82
95Cancellation fairness70
93Member support72

Price, coverage & features

MetricCoreAge RxTryozi
Verdict Score94/10076/100
GradeAC
Semaglutide$99/mo$279/mo
Tirzepatide$149/mo$379/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualNoNo

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Tryozi

What we like

  • Names all four 503A compounding pharmacies in the footer: RedRock, Health Warehouse, Precision Medicine and Triad Rx
  • Brand-name Ozempic at $1,299/mo and Zepbound at $1,399/mo are sold alongside the compounded tiers
  • States in writing that 'your monthly price doesn't jump as your dose increases'
  • Both the discounted first-month figure and the ongoing rate are printed together on the pricing card, before any intake
  • Available in all 50 states plus D.C., with eligibility checked free and without an account

The caveats

  • Compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, efficacy or manufacturing consistency
  • The $139 and $189 headline figures are a 50% first-month offer only; the ongoing rates are $279 and $379
  • Multi-week plans (12/24/52-week, -22%/-29%/-47%) are billed once upfront, not as a lower monthly rate
  • Plans ship every four weeks, so a 52-week plan is 13 shipments rather than 12 calendar months
  • No refund terms are published on the pricing page, and support hours are not stated

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Also worth a look

Buyers who want the compounding pharmacy named outright and a price that does not climb as the dose escalates.

Visit Tryozi Read the full Tryozi review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Tryozi does the reverse.

Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.